Billionaire investor Carl Icahn is seeking antitrust approval to purchase $500 million of ImClone Systems stock -- roughly 40 percent of the company -- prompting the New York biotech firm to take steps to defend itself against a takeover. A plan adopted by ImClone makes it prohibitively expensive for an investor to continue buying shares of the company once he controls 15 percent of all stock.
February 18, 2002 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania with their dedication to law.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
Attorneys Solicitor General Division: The West Virginia Attorney General's Office is accepting applications for attorneys in the Solicitor...
Regional mid-sized firm with diverse civil litigation practice seeking hardworking and dedicated attorneys with 1-5 years experience for it...
HARTMANN DOHERTY ROSA BERMAN & BULBULIA LLC's Matrimonial & Family Practice Warmly Welcomes the Honorable Peter J. Melchionne (Ret.) to Lead its New Family Law Dispute Resolution Team.
